| Serial Number | 86383746 |
| Word Mark | OPTIMµM |
| Filing Date | Wednesday, September 3, 2014 |
| Status | 702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Thursday, July 8, 2021 |
| Registration Number | 4802411 |
| Registration Date | Tuesday, September 1, 2015 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 16, 2015 |
| Goods and Services | Manufacturing services for others in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, taste masked release, and delayed release systems, clinical manufacturing of drug formulations for others to support clinical trials, fabrication and preparation of active pharmaceutical ingredients for others, technology scale-up services for others, and integration of technology into manufacturing processes for others, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for oral delivery |
| Pseudo Mark | OPTIMUM |
| Goods and Services | Pharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development services, namely, research and development in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, taste masked release, and delayed release systems, consisting of selection of drug formulation and delivery systems to optimize performance of active pharmaceutical ingredients, analytic techniques to test drug formulations, analytic services to detect, identify and quantify drug components, stability testing, physical characterization of drug formulations, in-vitro release testing, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for oral delivery |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 9, 2015 |
| Primary Code | 040 |
| First Use Anywhere Date | Friday, August 15, 2014 |
| First Use In Commerce Date | Friday, August 15, 2014 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 12, 2014 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, August 15, 2014 |
| First Use In Commerce Date | Friday, August 15, 2014 |
| Party Name | Adare Pharmaceuticals USA, Inc. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 03 - Corporation |
| Address | Lawrenceville, NJ 08648 |
| Party Name | Orbis Biosciences, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Kansas City, KS 66103 |
| Party Name | Orbis Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Kansas City, KS 66103 |
| Party Name | Orbis Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Kansas City, KS 66103 |
| Event Date | Event Description |
| Saturday, September 13, 2014 | NOTICE OF PSEUDO MARK E-MAILED |
| Saturday, September 6, 2014 | NEW APPLICATION ENTERED |
| Friday, September 12, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, December 14, 2014 | ASSIGNED TO EXAMINER |
| Wednesday, April 8, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 19, 2014 | NON-FINAL ACTION WRITTEN |
| Friday, December 19, 2014 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, December 19, 2014 | NON-FINAL ACTION E-MAILED |
| Wednesday, April 8, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 9, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 15, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, May 9, 2015 | ASSIGNED TO LIE |
| Saturday, May 9, 2015 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, May 27, 2015 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 1, 2020 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Wednesday, February 24, 2021 | TEAS SECTION 8 & 15 RECEIVED |
| Tuesday, June 16, 2015 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 16, 2015 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 1, 2015 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, April 26, 2016 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, April 26, 2016 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, October 7, 2020 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Wednesday, October 14, 2020 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Thursday, July 8, 2021 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Sunday, September 1, 2024 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| Thursday, July 8, 2021 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Thursday, July 8, 2021 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |